Applied DNA Sciences (NASDAQ:APDN) reported its Q2 earnings results on Thursday, May 12, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Applied DNA Sciences beat estimated earnings by 30.3%, reporting an EPS of $-0.23 versus an estimate of $-0.33.
Revenue was up $3.48 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.36 which was followed by a 15.11% drop in the share price the next day.
Here's a look at Applied DNA Sciences's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.27 | -0.37 | -0.22 | -0.21 |
| EPS Actual | -0.63 | -0.60 | -0.46 | -0.33 |
| Revenue Estimate | 4.02M | 2.30M | 3.13M | 2.60M |
| Revenue Actual | 4.17M | 3.00M | 1.70M | 2.67M |
To track all earnings releases for Applied DNA Sciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
